KCM Investment Advisors’s Biogen BIIB Stock Holding History

KCM Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$605K	Sell	2,799 -4	-0.1%	-$765	0.02%	261
2026 Q1	$514K	Buy	2,803 +4	+0.1%	+$737	0.02%	264
2025 Q4	$493K	Hold	2,799	–	–	0.02%	272
2025 Q3	$392K	Sell	2,799 -20	-0.7%	-$2.7K	0.01%	290
2025 Q2	$354K	Sell	2,819 -20	-0.7%	-$2.49K	0.01%	296
2025 Q1	$388K	Sell	2,839 -105	-4%	-$15K	0.01%	276
2024 Q4	$450K	Hold	2,944	–	–	0.02%	265
2024 Q3	$571K	Hold	2,944	–	–	0.02%	251
2024 Q2	$682K	Sell	2,944 -9	-0.3%	-$1.96K	0.02%	240
2024 Q1	$637K	Buy	2,953 +48	+2%	+$11.2K	0.02%	245
2023 Q4	$752K	Sell	2,905 -14	-0.5%	-$3.44K	0.03%	224
2023 Q3	$750K	Hold	2,919	–	–	0.03%	218
2023 Q2	$831K	Hold	2,919	–	–	0.03%	220
2023 Q1	$812K	Hold	2,919	–	–	0.03%	225
2022 Q4	$808K	Sell	2,919 -4	-0.1%	-$1.13K	0.03%	223
2022 Q3	$780K	Hold	2,923	–	–	0.04%	219
2022 Q2	$596K	Sell	2,923 -1	-0%	-$204	0.03%	247
2022 Q1	$616K	Sell	2,924 -236	-7%	-$51.3K	0.02%	258
2021 Q4	$758K	Hold	3,160	–	–	0.03%	236
2021 Q3	$894K	Buy	3,160 +11	+0.3%	+$3.6K	0.04%	215
2021 Q2	$1.09M	Sell	3,149 -384	-11%	-$116K	0.04%	198
2021 Q1	$988K	Sell	3,533 -177	-5%	-$47.7K	0.04%	198
2020 Q4	$908K	Sell	3,710 -288	-7%	-$74.3K	0.04%	195
2020 Q3	$1.13M	Sell	3,998 -202	-5%	-$56.3K	0.06%	164
2020 Q2	$1.12M	Buy	4,200 +47	+1%	+$14.1K	0.06%	167
2020 Q1	$1.31M	Buy	4,153 +104	+3%	+$31.6K	0.09%	139
2019 Q4	$1.2M	Sell	4,049 -20	-0.5%	-$5.55K	0.07%	165
2019 Q3	$947K	Hold	4,069	–	–	0.06%	178
2019 Q2	$952K	Sell	4,069 -10	-0.2%	-$2.31K	0.06%	174
2019 Q1	$964K	Sell	4,079 -20	-0.5%	-$6.3K	0.06%	173
2018 Q4	$1.23M	Hold	4,099	–	–	0.08%	204
2018 Q3	$1.45M	Hold	4,099	–	–	0.08%	195
2018 Q2	$1.19M	Buy	4,099 +145	+4%	+$40.8K	0.07%	212
2018 Q1	$1.08M	Sell	3,954 -405	-9%	-$126K	0.07%	244
2017 Q4	$1.39M	Sell	4,359 -111	-2%	-$35.6K	0.08%	222
2017 Q3	$1.4M	Buy	4,470 +10	+0.2%	+$2.96K	0.09%	218
2017 Q2	$1.21M	Sell	4,460 -25	-0.6%	-$6.61K	0.08%	234
2017 Q1	$1.23M	Sell	4,485 -150	-3%	-$42.4K	0.08%	232
2016 Q4	$1.31M	Buy	4,635 +1	+0%	+$296	0.09%	219
2016 Q3	$1.45M	Sell	4,634 -77	-2%	-$22.8K	0.1%	211
2016 Q2	$1.14M	Sell	4,711 -60	-1%	-$15.8K	0.08%	232
2016 Q1	$1.24M	Buy	4,771 +7	+0.1%	+$1.85K	0.09%	218
2015 Q4	$1.46M	Sell	4,764 -849	-15%	-$244K	0.12%	192
2015 Q3	$1.64M	Buy	5,613 +1,380	+33%	+$456K	0.14%	185
2015 Q2	$1.71M	Sell	4,233 -21	-0.5%	-$8.43K	0.14%	193
2015 Q1	$1.8M	Sell	4,254 -130	-3%	-$51.2K	0.14%	181
2014 Q4	$1.49M	Sell	4,384 -143	-3%	-$46.3K	0.13%	200
2014 Q3	$1.5M	Hold	4,527	–	–	0.14%	192
2014 Q2	$1.43M	Buy	4,527 +336	+8%	+$101K	0.13%	192
2014 Q1	$1.28M	Sell	4,191 -91	-2%	-$28.9K	0.13%	191
2013 Q4	$1.2M	Sell	4,282 -222	-5%	-$57.4K	0.13%	186
2013 Q3	$1.08M	Sell	4,504 -158	-3%	-$35.4K	0.13%	190
2013 Q2	$1M	Buy	+4,662	New	+$996K	0.12%	196

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM Investment Advisors's BIIB Position: Q2 2026 in Review

KCM Investment Advisors reduced its Biogen (BIIB) stake by 0.14% in Q2 2026, selling an estimated $765 and leaving 2,799 shares worth $605K. The position accounts for 0.02% of the portfolio, ranked #261.

KCM Investment Advisors first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.8M in Q1 2015. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

KCM Investment Advisors held 2,799 shares of Biogen worth $605K as of Q2 2026.
KCM Investment Advisors sold 4 Biogen shares in Q2 2026, an estimated $765.
Biogen made up 0.02% of KCM Investment Advisors's portfolio in Q2 2026, its #261 holding.
KCM Investment Advisors first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
KCM Investment Advisors's Biogen position peaked at $1.8M in Q1 2015.
1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on KCM Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.